Clinical trial
Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
NCT03332264 is registered in ClinicalTrials.gov with InnoRa GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
- Lead sponsor
- InnoRa GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 30, 2017
- Completion date
- December 12, 2023
- Enrollment
- 224 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
occlusion, restenosis, stenosis